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Summary This report concerns a screening programme for colorectal cancer using Fecatest, a relatively
sensitive test for faecal occult blood, in a factory-based population. A total of 2420 workers between 40 and
65 years of age returned kits for testing following suitable dietary restriction. In Factory A, in which
screening was offered as part of an annual medical examination, 989 men agreed to participate, a compliance
rate of 45%. In Factory B, in which screening was offered in their weekly pay packets, 1431 men participated,
a compliance rate of 22%. An overall positivity rate of 5.8% was found, 4.6% in Factory A and 6.6% in
Factory B. Five cancers were found, two of the rectum, one at the recto-sigmoid junction, one in the sigmoid
colon and one in the transverse colon. Two of these lesions were at Dukes Stage A, one at Stage B and two
at Stage C. In addition, 25 adenomatous polyps were found in 17 men. In 13 these were characterized as
tubular adenomata and in 4 as tubulovillous adenomata. The mean age at diagnosis in the polyp cases was
52.6 years and in the cancer cases 58.8 years. Increased specificity is obtained by excluding participants below
46 years of age. The detection rate in the 46-65 year range is - 1 in 100 for adenomatous polyps and 1 in 300
for cancer in the population screened. This detection rate is higher than most comparable studies using a less
sensitive Guaiac test on older populations.
The high incidence of colorectal cancer in Western
communities (Office of Population 1975; Cancer
Facts & Figures 1977) has led to the introduction
of screening programmes with the aim of increasing
the proportion of localised (Dukes A & B) cancer
at presentation. Two studies utilizing
sigmoidoscopy and polyp removal suggested that
such a programme might reduce the incidence of
colorectal cancer although no control observations
were made (Hertz et al., 1960; Gilbertsen, 1973).
Dales et al. (1973) demonstrated reduced mortality
from colorectal cancer utilizing sigmoidoscopy in a
screened group compared with controls. Greegor
(1971) popularised the Guaiac test for faecal occult
blood as a screening test to select a proportion of
asymptomatic individuals for fuller investigation of
the large bowel. Subsequently, the Haemoccult II
test has been widely used in screening programmes
with the finding of -1 carcinoma per 500-1000
persons screened (Glober & Peskoe, 1974; Miller
and Knight 1977; Bralow, 1979). In addition, in
recent programmes in which colonoscopy was
employed -3 times as many adenomatous polyps
as cancers were discovered (Winawer et al., 1977;
Fruhmorgen & Demling, 1980). It is hoped that
removal of polyps by snare polypectomy may also
reduce the incidence of subsequent cancer in view
of the known tendency for such lesions to pass
from a benign to a malignant phase (Grinnell &
Lane 1958; Morson, 1966). A number of screening
programmes have been carried out and early results
of two controlled studies (Winawer et al., 1980;
Hardcastle et al., 1983) indicate benefit for the
screened population in terms of increased diagnosis
of localized lesions (Dukes A & B) with
corresponding improved prognosis (Bussey, 1963;
Gill & Morris, 1978). Problems remaining relate to
identification and compliance of the population to
be screened, the sensitivity and specificity of the
tests involved and the cost/benefit of the
programme compared with any disadvantage from
physical and psychological injury involved in the
investigative programme. This study reports the
results of a screening programme for colorectal
cancer in a factory-based population using Fecatest.
Methods
Fecatest
The Fecatest paper is fitted between 2 plastic
compartments, the patient applying one small
specimen of faeces to one side of the paper and the
test is completed on the other side. Fecatest has a
sensitivity just above what is regarded as normal
blood loss -2.5-5.0ml day-l (Adlercreutz et al.,
1978). Two factory groups were studied, the
programme being aimed at male workers aged
between 40 and 65 years.
Factory A
Employees were offered screening for colorectal
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cancer as part of their annual medical examination.
Nurses from the Occupational Health Department
gave written and verbal instructions with regard to
the faecal occult blood tests. Completed kits were
returned to the factory Medical Department where
they were interpreted by trained laboratory
technicians.
Factory B
The same screening programme was offered to
employees by written invitation in their pay
packets. They attended the factory Medical
Department to collect the kits from nursing staff
who gave verbal and written instructions.
Completed kits were sent by post to the
Department of Gastroenterology, Victoria Hospital,
Blackpool, for interpretation.
Participants were invited to complete a
questionnaire relating to family history of cancer,
and current drug usage, notably antirheumatic and
analgesic agents.
As recommended by the manufacturers, the kits
were used on 3 successive stools, or days on which
stools were passed, following a 3-day period of
dietary restriction. Red meat and some vegetables
and fruit contain peroxidase activity and for more
specific results individuals should take a diet
excluding red meat, liver, bananas, swede, tomatoes
and turnips. Fish and chicken are allowed. A diet
containing vegetables and wholemeal bread is
recommended. Vitamin C may produce false
negative tests and patients are advised to exclude
such preparations.
Workers with one or more positive test were
investigated by flexible sigmoidoscopy, barium
enema and colonoscopy in the Gastroenterology
and Radiology Departments, Victoria Hospital.
Polyps were removed by snare polypectomy.
Where appropriate, statistical differences between
groups were calculated using the Chi square test.
Results
Compliance
In Factory A, in which screening was offered to
workers as part of an annual medical examination,
45% returned the test kits. In contrast, in Factory
B, in which screening was offered in the pay packet,
response was only 22% of those approached.
(P<0.001).
Positivity rate
The combined positivity rate for the two factories
was 5.8%, for Factory A it was 4.6% and for
Factory B 6.6%. This difference is significant
(P<0.05). The majority of Fecatest positive
participants completed the investigation
programme. Only 8 men withdrew, 6 after flexible
sigmoidoscopy and 2 after the barium enema
examination.
Pathologicalfindings
The findings in the total group and the 2 factories
are shown in Table I. Five cancers were found, 2 at
Dukes Stage A, one at Stage B and 2 at Stage C.
Details of these are shown in Table II. Twenty-five
adenomatous polyps were found in 17 men. In 13
men the lesions were characterized as tubular
adenomata and in 4 as tubulovillous adenomata.
Four men were found to have occult inflammatory
Table I Results of screening programme in total
participants and Factories A & B
Total Factory A Factory B
Number screened 2,420 989 1,431
Fecatest
positive 140(5.8%) 45(4.6%) P<0.05 95(6.6%)
Adenomatous
polyps 17 3 NS 14
Cancer 5 3 NS 2
I.B.D. 4 1 NS 3
Diverticular
disease 23 8 NS 15
Perianal disease 50 15 NS 35
Nil ("false
positive") 52(32%) 17 NS 35
(Some men had more than one lesion).
Table II Cases ofcolorectal cancer
Surgical Dukes
Case Age Site procedure Details grade
C1 60 Rectum Abdomino- Lymph node A
perineal involved 0/6
resection
C2 61 Recto- Anterior Into M. propria B
sigmoid resection Lymph node
15cm from involved 0/0
anus
C3 54 Rectum Abdomino- 6cm diam. into C
perineal M. propria
resection Lymph node
involved 1/6
C4 58 Sigmoid Resection 1 x 1.5cm diam. C
35cm from into submucosa
anus Lymph node
involved 1/6
CS 61 Mid Resection Polypoid. No A
transverse invasion. Lymph
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bowel disease. In addition, a proportion of men
were found to have perianal disease or diverticular
disease although the significance of these as causes
of occult blood loss is dubious. The remaining so-
called false positive cases were not investigated for
upper gastrointestinal disease, prior consent not
having been obtained. No patient had reported
gastro-intestinal symptoms or rectal bleeding and
none had anaemia.
Table III shows the age at diagnosis in the 17
men in whom adenomatous polyps were found and
the size of the largest polyp. One man had 3
polyps, 6 men had 2 and 10 had only 1 polyp.
Twelve patients had polyps >1 cm in diameter. All
except 1 polyp were removed by snare
polypectomy. The exception had a small (0.4cm)
polyp in an area of diverticular disease with a
tortuous narrow sigmoid colon which, in spite of
two attempts, could not be successfully snared.
Table III Diameter' of adenomatous polyps
and age at diagnosis
Age range-
years No. <1 cm 1-2cm >2cm
Under 46 2 0 1 1
46-50 5 2 3 0
51-55 5 1 1 3
56-60 3 2 1 0
61-65 2 0 1 1
All 17 5 7 5
'Where more than one polyp was present, the
diameter of the largest is given.
Surgical resection of the area was carried out
without complication. All the polyps and 4/5
cancers were found distal to the splenic flexure.
One large malignant polyp was situated in the mid-
transverse colon. The mean age at diagnosis of the
17 polyps was 52.6 years and of the 5 cancers 58.8
years. It may reasonably be speculated that removal
of the benign lesions may be associated with
prevention of malignant disease later. The
predictive value of the screening test is improved by
excluding individuals under 46 years of age (Table
IV). The detection rate in the 46-65 years age range
is 1 in 100 for adenomatous polyps and 1 in 300 for
cancer in the population screened.
In the 22 men in whom polyps and cancers were
found, digital examination of the rectum revealed
two cancers. At flexible sigmoidoscopy 13 polyps
and 4 cancers were visible and on barium enema
examination 8 polyps were noted, but 3 of these
had not been visible at sigmoidoscopy.
Colonoscopy revealed one polyp and one cancer
not visible within the range of the flexible
sigmoidoscopy nor on barium enema. The cancer
was not seen on a single contrast examination but
was visible in the transverse colon when the double
contrast technique was used after colonoscopy.
Discussion
The decision to use Fecatest, a more sensitive
Guaiac test for faecal occult blood than the
previously more popular Haemoccult, was
prompted by an earlier finding of Fecatest positive
Table IV Screening for colorectal cancer in the United Kingdom: Details and analysis of studies
Positive CA+polyp(CA)
tests CA+polyp(CA) %/no.
Guaiac no. Percentage CA+polyp %/no. F.O.B. positive.
Reference Population Age range test screened positive (CA) screened (predictive value)
Hardcastle General
& Balfour practice >45 H* 27/713 3.8 6 (2) 0.84 (0.22) 22.2 (7.4)
(1980)
Farrands General
et al. practice >40 H* 124/2439 5.0 12 (4) 0.49 (0.16) 9.6 (3.2)
(1981)
Million General
et al. practice >45 H* 37/1646 2.3 7 (2) 0.43 (0.12) 18.9 (5.4)
(1982)
Lee (1983) Factory
based 40-65 F** 140/2420 5.8 22 (5) 0.9 (0.21) 15.7 (3.6)
Lee (1983) Factory
based 46-65 F** 92/1575 5.8 20 (5) 1.27 (0.32) 21.7 (5.4)
H*-Haemoccult.
F**-Fecatest.
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Haemoccult negative colorectal cancers (Lee &
Costello 1982). Several reports indicate that an
undetermined number of colorectal cancers are
Haemoccult negative (Griffith et al., 1981; Ribet et
al., 1980; Gnauck, 1980) and a false negative rate
of 76% for rectosigmoid polyps has been reported
(Winawer et al., 1977). Positive Haemoccult tests
can convert to negative after a few days' storage
(Fleisher et al., 1977; Heinrich et al., 1980) and this
is relevant where participants send in their
specimens by post. The positivity rate for
Haemoccult can be increased by rehydration but
some loss of specificity may occur (Fleisher et al.,
1977).
Although the majority of studies to date involve
Haemoccult, there have been suggestions that a
more sensitive test would be useful (Vellacott et al.,
1981; Williams et al., 1982). The use of Fecatest in
this study has been associated with higher detection
rates for colorectal cancer compared with other
U.K. series based on general practice populations
without a lowering of the predictive value of the
basic screening test (Table IV).
Using a more sensitive test may result in an
increase in false positivity and one problem here
relates to the possibility that upper gastro-intestinal
disease may be responsible for positive faecal occult
blood tests in asymptomatic patients. With a
sensitive test such as Fecatest the importance of
proper dietary restriction should be stressed. This
requires explanation to participants and a strong
motivation to co-operate. It may be that these
requirements are more likely to be met in screening
a relatively young population, such as that based
on place of work, rather than in surveys based in
general practice, which usually include a higher
proportion of elderly participants.
Although flexible sigmoidoscopy is useful in
surveillance it cannot replace double contrast
barium enema or colonoscopy since up to 50% of
lesions may be beyond the range of the instruments.
In this series 17/22 cancers and polyps (77%) were
visible on flexible sigmoidoscopy. This high yield
may reflect the relatively young population
involved, since the incidence of right sided lesions
increases with age (Slater et al., 1982). In one large
series, 95% of malignant polyps were located distal
to the splenic flexure (Appel, 1982) and in another
large colonoscopic study only 34% of polyps and
36% of cancers were located beyond the range of
the flexible sigmoidoscope (Tedesco et al., 1980).
Clearly examination of the whole colon in screening
programmes is needed, but it seems that the
diagnostic return is likely to be less in the right
colon, the younger the population studied. Fork
(1981) has compared the diagnostic accuracy of
double contrast barium enema as assessed by
colonoscopy and concluded that when both
techniques are used only few polyps will be missed.
The need for careful radiographic techniques is
stressed.
Our finding of a co-operation rate of 45% in
Factory A compared with 22% in Factory B
coincides with previous observation that acceptance
is more likely in groups attending for regular
medical examination (Glober & Peskoe, 1974;
Winawer et al., 1977). Hardcastle et al. (1980)
noted that in a general practice population
compliance was highest in the age range 50-65
years declining sharply over 75 years of age. There
was an overall compliance rate of 45% in their
study compared with 27% in the "Frome
experience" (Farrands et al., 1981) and 28% in
Salford (Million et al., 1982). If screening
programmes are demonstrated to be beneficial in
terms of early diagnosis and prevention of
colorectal cancer, more research is needed into
optimum recruitment procedures (Halper et al.,
1980; Hardcastle et al., 1983).
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